Canalevia® (crofelemer delayed-release tablets), under the name Canalevia-CA1, is conditionally approved by the FDA for ...

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ...

Ever wish that you could make your dog's life longer? While crossing the rainbow bridge is part of a dog's short life, ...

The FDA has approved Yeztugo for PrEP to reduce the risk of sexually acquired HIV-1 in adults and adolescents weighing at least 35kg.

The Food and Drug Administration (FDA) has approved Harliku ™ (nitisinone) for the reduction of urine homogentisic acid (HGA) in adult patients with alkaptonuria.

MORE medicines for cancer, diabetes, high cholesterol, hypertension, tuberculosis and mental diseases have been exempted from 12-percent value-added tax (VAT) by the Bureau of Internal Revenue (BIR).

The FDA didn’t routinely test the medications for quality problems or use its vast repository of drug-related complaints to ...

LIKMEZTM (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL re-launched and commercial sales ongoing Five U.S. government proposals s ...

Viking Therapeutics initiates VANQUISH phase 3 obesity clinical programme with GLP-1/GIP agonist VK2735: San Diego Thursday, June 26, 2025, 10:00 Hrs [IST] Viking Therapeutics, In ...

Phathom gains FDA exclusivity for VOQUEZNA through 2032, boosting stock. DCF values shares at $14 with 43% upside potential.

The Bureau of Internal Revenue (BIR) has issued a memorandum including 10 medicines in the list of drugs exempted from ...

Detailed Phase IIIb STEP UP trial results presented at the 2025 ADA Scientific Sessions found that an investigational 7.2 mg dose of Wegovy (semaglutide) led to a mean weight loss of 21% in adults ...